In a world heavily focused on therapeutic options for multidrug-resistant gram-negative organisms, the emergence of antimicrobial resistance among enterococci is often an under-recognized risk.
Eleanor Sadler, PharmD, BCIDP
Advertisement
Sadler is an infectious diseases clinical pharmacy specialist and a member of the Antimicrobial Stewardship Program at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Her research interests include multidrug-resistant gram-negative pathogens, pharmacokinetics and pharmacodynamics, and outpatient antimicrobial stewardship.
Articles by Eleanor Sadler, PharmD, BCIDP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint
2
Dynavax Presents Data for Shingles Vaccine, Launches Head-to-Head Study Against Shingrix
3
Meet SIDP’s President Elect: Lisa Dumkow, PharmD, FIDP, BCIDP
4
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
5
